Evidence map›Paper›PMID 36591151›Full record

ArticleACS omega2022

Organotrifluoroborate Sugar Conjugates for a Guided Boron Neutron Capture Therapy: From Synthesis to Positron Emission Tomography.

Laura Confalonieri, Daniela Imperio, Alvaro Erhard, Silvia Fallarini, Federica Compostella, Erika Del Grosso, Marcin Balcerzyk, Luigi Panza

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Laura ConfalonieriDepartment of Pharmaceutical Sciences, University of Eastern Piedmont Amedeo Avogadro, L.go Donegani 2/3, 28100 Novara, Italy.ORCID https://orcid.org/0000-0002-0236-9659
Daniela ImperioDepartment of Pharmaceutical Sciences, University of Eastern Piedmont Amedeo Avogadro, L.go Donegani 2/3, 28100 Novara, Italy.ORCID https://orcid.org/0000-0001-6810-1439
Alvaro ErhardCentro Nacional de Aceleradores, Universidad de Sevilla-CSIC-Junta de Andalucia, 41092 Sevilla, Spain.
Silvia FallariniDepartment of Pharmaceutical Sciences, University of Eastern Piedmont Amedeo Avogadro, L.go Donegani 2/3, 28100 Novara, Italy.
Federica CompostellaDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Via Saldini 50, 20133 Milano, Italy.ORCID https://orcid.org/0000-0003-4721-0358
Erika Del GrossoDepartment of Pharmaceutical Sciences, University of Eastern Piedmont Amedeo Avogadro, L.go Donegani 2/3, 28100 Novara, Italy.
Marcin BalcerzykCentro Nacional de Aceleradores, Universidad de Sevilla-CSIC-Junta de Andalucia, 41092 Sevilla, Spain.
Luigi PanzaDepartment of Pharmaceutical Sciences, University of Eastern Piedmont Amedeo Avogadro, L.go Donegani 2/3, 28100 Novara, Italy.ORCID https://orcid.org/0000-0002-0785-0409

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sugars are a versatile tool for targeting malignant cells and have been extensively used for drug delivery and imaging techniques. Their prototype, fluorodeoxyglucose ([

Identifiers

PMID36591151
PMCPMC9798496

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.